Instrumented spinal fusion method impacts infection rate

Instrumented spinal fusion method impacts infection rate

(HealthDay) -- For patients who undergo instrumented spinal fusion, the rates of infection are higher among those who receive posterior lumbar interbody fusion compared with those who receive posterior or posterolateral fusion, according to a study published online May 10 in the Journal of Spinal Disorders & Techniques.

Dong Ki Ahn, M.D. of the Seoul Sacred Heart General Hospital in Korea, and associates conducted a retrospective analysis of 3,084 patients who had instrumental surgeries between 2000 and 2009. The difference in the rates and characteristics of surgical site infections were compared for patients who underwent posterior or posterolateral fusion (Group I; 974 patients) and those who underwent posterior lumbar interbody fusion (Group II; 2,110 ).

The researchers observed a significant difference in the rate between groups I and II (0.3 versus 1.37 percent; P = 0.003). Of the infections in group I, 67 percent were wound infections and 33 percent were osteomyelitis. The infections in group II were mainly osteomyelitis (73 percent), with 23 percent wound infections and 4 percent osteomyelitis combined with wound infection. In the single cage group and mainly local bone grafted group, there was a significantly increased infection rate.

"The infection rate of posterior lumbar interbody fusion was higher than that of posterior or posterolateral fusion," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Study tests unilateral versus bilateral lumbar fusion

Apr 09, 2012

(HealthDay) -- For patients with degenerative lumbar diseases, the unilateral pedicle screw (PS) instrumented transforaminal lumbar interbody fusion (TLIF) procedure results in shorter operative time, less ...

Complications rise along with off-label use of BMP-2

Sep 06, 2010

When the U.S. Food and Drug Administration in 2002 approved a product many thought would revolutionize back surgery, the agency did so despite concerns the product might cause serious side effects.

Recommended for you

Breakthrough in managing yellow fever disease

2 hours ago

Yellow fever is a disease that can result in symptoms ranging from fever to severe liver damage. Found in South America and sub-Saharan Africa, each year the disease results in 200,000 new cases and kills ...

Don't worry about Ebola—but be very worried about flu

6 hours ago

Amidst fears about the Ebola virus, the current flu season is gaining steam. And many Americans, while completely safe from Ebola, are in danger of becoming seriously ill with a widespread, highly infectious and potentially ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.